RECRUITINGOBSERVATIONAL
Therapeutic Recommendations for Nephroblastoma
Therapeutic Recommendations for the Treatment of Children With Nephroblastoma in Africa.
About This Trial
The study is based on results form 2 previous studies carried out by the GFAOP. The aim of this study is to evaluate the capacity of units to follow the recommendations in the protocol.
Who May Be Eligible (Plain English)
Who May Qualify:
Unilateral Nephroblastoma Tumor Not previously treated The general health of the child will permit treatment.
.
Who Should NOT Join This Trial:
Bilateral Nephroblastoma tumor Previously treated Disease too advanced Doubt concerning the diagnosis Treatment Refusal
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
Unilateral Nephroblastoma Tumor Not previously treated The general health of the child will permit treatment.
.
Exclusion Criteria:
Bilateral Nephroblastoma tumor Previously treated Disease too advanced Doubt concerning the diagnosis Treatment Refusal
Treatments Being Tested
OTHER
Data collection
Clinical stage, treatment given and observations of toxicity if any, outcome following treatment and follow up.
Locations (7)
Centre Hospitalier Universitaire Pédiatrique Charles De Gaulle
Ouagadougou, Burkina Faso
CHU de Treichville à ABIDJAN
Abidjan, Abidjan Autonomous District, Côte d’Ivoire
CUK (Cliniques Universitaires de Kinshasa)
Kinshasa, Democratic Republic of the Congo
Cliniques Universitaires de Lubumbashi (CUL)
Lubumbashi, Democratic Republic of the Congo
HJRA, Hôpital universitaire Joseph Ravoahangy Andrianavalona
Antananarivo, Madagascar
CHU Gabriel Touré (HGT)
Bamako, Mali
Hôpital Aristide Le Dantec, Avenue Pasteur, BP 3001
Dakar, Dakar, Senegal